Skip to main content

Table 2 Comparison of acne variables in case and control groups during one and three months

From: The investigation of the efficacy and safety of stromal vascular fraction in the treatment of nanofat-treated acne scar: a randomized blinded controlled clinical trial

  Baseline After 1 month After 3 months Change%
p value
Mean SD Mean SD Mean SD Baseline to Month1 Baseline to Month3 Month1 to Month3
Volume
Control 134.45 78.88 99.86 40.97 − 18.12%
0.112
Case 131.90 63.04 84.23 44.41 − 33.87%
0.026
Area
Control 11.43 5.52 9.36 3.69 − 14.97%
0.069
Case 12.66 5.68 8.43 3.87 − 30.03%
0.033
Depth
Control 10.86 1.57 10.14 0.90 − 5.06%
0.310
Case 9.86 1.07 9.14 0.90 − 6.88%
0.047
Epidermal thickness
Control 67.71 8.69 78.28 7.91 83.75 21.03 + 16.17%
0.001
+ 33.75%
0.158
+ 12.91%
0.360
Case 66.43 9.91 85.43 12.82 85.25 8.46 + 30.24%
0.009
+ 41.95%
0.064
+ 9.50%
0.378
Dermal thickness
Control 687.71 110.53 801.14 111.90 893.75 47.89 + 17.89%
0.033
+ 29.59%
0.042
+ 10.40%
0.119
Case 629.43 111.49 965.57 155.36 981.25 78.57 + 58.81%
0.008
+ 61.27%
0.002
+ 11.11%
0.101
Complete thickness
Control 755.43 112.47 879.43 113.30 977.50 66.14 + 17.65%
0.028
+ 29.75%
0.045
+ 29.75%
0.093
Case 695.86 114.65 1051.00 161.84 1066.50 71.39 + 55.45%
0.007
+ 58.99%
0.001
+ 10.89%
0.101
  1. p numbers based on paired t test